REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 17 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,005,748 | -16.7% | 615,932 | 0.0% | 0.00% | – |
| Q2 2023 | $3,609,361 | +50.1% | 615,932 | +7.3% | 0.00% | – |
| Q1 2023 | $2,404,096 | +21.3% | 573,770 | +23.0% | 0.00% | – |
| Q4 2022 | $1,982,272 | +206.9% | 466,417 | +14.8% | 0.00% | – |
| Q3 2022 | $646,000 | +26.4% | 406,394 | -12.6% | 0.00% | – |
| Q2 2022 | $511,000 | -55.4% | 464,808 | -0.2% | 0.00% | – |
| Q1 2022 | $1,146,000 | -19.7% | 465,508 | -5.8% | 0.00% | – |
| Q4 2021 | $1,428,000 | -31.1% | 494,408 | -2.9% | 0.00% | – |
| Q3 2021 | $2,072,000 | -19.5% | 509,056 | -3.9% | 0.00% | – |
| Q2 2021 | $2,573,000 | – | 529,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |